Fibromiyalji Hastalarında Aleksitimi ve Yaşam Kalitesi Üzerine Etkisi

Objective & Hypothesis:Objective: Alexithymia, a personal trait characterized by difficulty in identifying feelings, is common among chronic pain patients.

📊

Key Findings & Data:Methods: A total of 70 patients with FM and 40 age- and sex-matched healthy controls were included in the study.

💡

Conclusion & Impact:FM patients scored significantly higher in TAS-20 than the controls (p

🔬Design:Survey & Empirical Study

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Objective: Alexithymia, a personal trait characterized by difficulty in identifying feelings, is common among chronic pain patients. In our study, we aimed to assess alexithymia in patients with fibromyalgia (FM), to determine its association with clinical parameters and depression, and to analyze its impact on the quality of life. Methods: A total of 70 patients with FM and 40 age- and sex-matched healthy controls were included in the study. Alexithymia was assessed using the 20-item Toronto Alexithymia Scale (TAS-20). The Fibromyalgia Impact Questionnaire (FIQ) was used for measuring disease severity. The quality of life was evaluated using the Nottingham Health Profile (NHP) and depression by the Beck Depression Scale (BDS). The Visual Analog Scale (VAS) was used for determining pain severity. Results: The prevalence of alexithymia was 24.29% in FM patients and 7.5% in controls. It was higher in patients with FM than in controls [Odds ratio (OR)=3.96, confidence interval (CI) 95% (1.08-14.48)] (p=0.028). FM patients scored significantly higher in TAS-20 than the controls (p

Özet

Amaç: Aleksitimi, duyguların tanımlanmasındaki zorlukla nitelendirilen karak-ter özelliği, kronik ağrı hastalarında yaygındır. Çalışmamızda, fibromiyalji (FM) hastalarında aleksitimiyi değerlendirmeyi, klinik parametrelerle ve depresyonla ilişkisini saptamayı ve yaşam kalitesi üzerine etkisini analiz etmeyi amaçladık. Yöntemler: Çalışmaya toplam 70 FM hastası ve 40 yaş ve cinsiyet uyumlu hasta dahil edildi. Aleksitimi 20 maddeli Toronto Aleksitimi Skalası [20-item Toronto Ale-xithymia Scale (TAS-20)] ile değerlendirildi. Hastalık şiddetini ölçmede Fibromiyalji Etki Anketi [Fibromyalgia Impact Questionnaire (FIQ)] kullanıldı. Yaşam kalitesi Nottingham Sağlık Profili [Nottingham Health Profile (NHP)] ile, depresyon ise Beck Depresyon Skalası [Beck Depression Scale (BDS)] ile belirlendi. Görsel Analog Skala [Visual Analog Scale (VAS)] ağrı şiddetini saptamak için kullanıldı. Bulgular: Aleksitimi prevalansı FM hastalarında %24,9 ve kontrollerde ise %7,5 idi. Kontrollerle karşılaştırıldığında FM hastalarında daha yüksekti [Odds oranı=3.96 güven aralığı 95% (1,08-14,48)] (p=0,028). FM hastaları kontrollerle karşılaştırıldı-ğında TAS-20'de daha yüksek skorlama gösterdiler (p

🔖

Cite This Article

ÖZTAŞ, D., GARİP, Y., TELCİ, Ş., TUNCER, Ö. B. (2022). Fibromiyalji Hastalarında Aleksitimi ve Yaşam Kalitesi Üzerine Etkisi. İstanbul Medical Journal, Cilt: 16 - Sayı: 4, 137–140. https://ajindex.com/articles/552148

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (2)

Clauw DJ. Fibromyalgia and Related Conditions. Mayo Clin Proc 2015; 90: 680-92. [CrossRef] Perrot S, Winkelmann A, Dukes E, Xu X, Schaefer C, Ryan K, et al. Char- acteristics of patients with fibromyalgia in France and Germany. Int J Clin Pract 2010; 64: 1100-8. [CrossRef] Tomasevic-Todorovic S, Pjevic M, Boskovic K. Fibromyalgia-up to date aspects of pathophysiology diagnosis and treatment. Med Pregl 2010; 63: 507-11. [CrossRef] Ricciardi L, Demartini B, Fotopoulou A, Edwards MJ. Alexithymia in Neuro- logical Disease: A Review. J Neuropsychiatry Clin Neurosci 2015; 27: 179-87. [CrossRef] Mattila AK, Kronholm E, Jula A, Salminen JK, Koivisto AM, Mielonen RL, et al. Alexithymia and somatization in general population. Psy- chosom Med 2008; 70: 716-22. [CrossRef] Sayar K, Gulec H, Topbas M. Alexithymia and anger in patients with fibromyalgia. Clin Rheumatol 2004; 23: 441-8. [CrossRef] Honkalampi K, Hintikka J, Tanskanen A, Lehtonen J, Viinamäki H. De- pression is strongly associated with alexithymia in the general popu- lation. J Psychosom Res 2000; 48: 99-104. [CrossRef] Pedrosa Gil F, Weigl M, Wessels T, Irnich D, Baumüller E, Winkelmann A. Parental bonding and alexithymia in adults with fibromyalgia. Psy- chosomatics 2008; 49: 115-22. [CrossRef] Castelli L, Tesio V, Colonna F, Molinaro S, Leombruni P, Bruzzone M, et al. Alexithymia and psychological distress in fibromyalgia: prevalence and relation with quality of life. Clin Exp Rheumatol 2012; 30: 70-7.
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Golden- berg DL, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Crite- ria Committee. Arthritis Rheum 1990; 33: 160-72. [CrossRef] Sarmer S, Ergin S, Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 2000; 20: 9-12. [CrossRef] Kucukdeveci AA, Mc Kenna SP, Kutlay S, Gürsel Y, Whalley D, Arasil T. The development and psycometric assessment of the Turkish version of the Nottingham Health Profile. Int J Rehabil Res 2000; 23: 31-8. [CrossRef] Beck AT, Ward C, Mendelson M, Mock J, Erbaugh J. An inventory for mea- suring depression. Arch Gen Psychiatry 1961; 4: 561-71. [CrossRef] Price DD, McGrath P, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983; 17: 45-56. [CrossRef] Güleç H, Köse S, Güleç MY, Çitak S, Evren C, Borckardt J, et a